Health Care & Life Sciences » Pharmaceuticals | iCo Therapeutics Inc.

iCo Therapeutics Inc.

iCo Therapeutics Inc.
Stock Exchange Other OTC
EPS
 $0.02
Market Cap
 $4.82 M
Shares Outstanding
 84.46 M
Public Float
 -
iCo Therapeutics Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
 CAD0.02
Market Cap
 CAD6.02 M
Shares Outstanding
 109.46 M
Public Float
 100.11 M

Profile

Address
777 Hornby Street
Vancouver British Columbia V6Z 2T3
Canada
Employees -
Website http://www.icotherapeutics.com
Updated 07/08/2019
iCo Therapeutics, Inc. engages in the business of identification, development and commercialization of drug candidates for the treatment of sight- and life-threatening diseases. Its products include iCo-008 and oral AmpB delivery system. The company was founded by Andrew J.

Financials

View All
Created with Highcharts 5.0.14iCo Therapeutics Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.5 6685 6682 0092 0091 7941 7941 4891 4891 2371 2371 7021 70220132014201520162017201801k2k3k4k5k6k

Andrew J. Rae
President, Chief Executive Officer & Director
Michael Liggett
Chief Financial Officer, Secretary & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.